Shandong Provincial Third Hospital — Jinan, Shandong

Public research footprint of Shandong Provincial Third Hospital, compiled from the ClinicalTrials.gov public registry.

Registered studies

Active

Recruiting now

Completed

Most-studied conditions

Post-ERCP Acute Pancreatitis · Unresectable or Metastatic Gastric/Gastroesophageal Junction… · Non-steroidal Anti-inflammatory (NSAID) · Non-steroid Anti-inflammatory Drugs

Recently updated registry entries

NCT06282575 — Efficacy and Safety of Zanidatamab With Standard-of-care Therapy Against Standard-of-care… (Recruiting)
NCT07587099 — Single vs. Dual Antiplatelet Therapy in Patients Undergoing Percutaneous Intervention… (Recruiting)
NCT07071441 — Indomethacin vs Diclofenac for Preventing PEP (Recruiting)

7 more recent registry entries at this facility

Enter your work email to view the full list.

I’d also like to receive occasional marketing emails from Eichor for research sites (optional — unsubscribe anytime).

Work at Shandong Provincial Third Hospital?

Verify and correct how your facility appears in public registry records — free.

Verify this profile →

Compiled from public registry records (ClinicalTrials.gov) as of August 05, 2026. Counts reflect how this facility appears in registry listings; name variants may exist and are not combined. This page describes public records only and makes no assessment of any facility.